23 November 2022

FAQs on the most important PRIIP requirements as of 01.01.2023

The provisions of Regulation (EU) No. 1286/2014 (PRIIPs Regulation) have been in force since 1 January 2018. Further details have been set out in regulatory technical standards in the form of Delegated Regulations (Regulation (EU) 2017/653, as most recently amended by Delegated Regulation (EU) 2021/2268).

The regulations concern what are known as packaged retail and insurance-based investment products (PRIIPs for short) and apply to all manufacturers and persons who advise on or sell them.

Exemptions currently still apply to the fund sector, but are set to expire at the end of 2022. From 1 January 2023, the PRIIPs rules will thus also be mandatory for the fund sector, which will entail some new challenges for funds and asset management companies as well as fund distributors.

Our GSK Update provides you with an overview of the key innovations that will apply from 2023 and that you should definitely be aware of in connection with the PRIIPs regulations.


Press contact
+49 30 203907-7763


GSK Updates
  • 17 May 2023

    GSK Update: German Tax Aspects for Inbound Investments

    Read more
  • 05 May 2023

    GSK Update: Real Estate Investments in Germany from a Tax Perspective

    Read more
  • 04 April 2023

    GSK Update: European Union institutions agree on a standard for EU Green Bonds – Current developments

    Read more
Contact person

Philippe Lorenz

Local Partner*

+49 89 288174-662


Lisa Baumann


+49 89 288174 95


For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral